英文字典中文字典51ZiDian.com

中文字典辞典英文字典 a b c d e f g h i j k l m n o p q r s t u v w x y z

begat 音标拼音: [bɪg'æt]

The Collaborative International Dictionary of English v.0.48 (gcide)

Beget \Be*get"\, v. t. [imp. {Begot}, (Archaic) {Begat}; p. p.
{Begot}, {Begotten}; p. pr. & vb. n. {Begetting}.] [OE.
bigiten, bigeten, to get, beget, AS. begitan to get; pref.
be- gitan. See {Get}, v. t. ]
1. To procreate, as a father or sire; to generate; --
commonly said of the father.
[1913 Webster]

Yet they a beauteous offspring shall beget.
--Milton.
[1913 Webster]

2. To get (with child.) [Obs.] --Shak.
[1913 Webster]

3. To produce as an effect; to cause to exist.
[1913 Webster]

Love is begot by fancy. --Granville.
[1913 Webster]

请选择你想看的字典辞典：

单词	字典	翻译
Begat	查看　Begat　在百度字典中的解释	百度英翻中〔查看〕
Begat	查看　Begat　在Google字典中的解释	Google英翻中〔查看〕
Begat	查看　Begat　在Yahoo字典中的解释	Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!

中文字典英文字典工具:

选择颜色:

<style type="text/css">#word104_1 br {display:none;}</style>
<form id="word104_1" method="post" action="http://se.goldgoldprice.com/index.php" target="_blank">
<div style="width: 140px;border:1px solid #000;background-color:#ffffff;padding: 0px 0px;margin: 0px 0px;align:center;text-align:center;overflow:hidden;"><div id="xcolor1_1" style="font-size:12px;color:#183a00;line-height:16px;font-family: arial; font-weight:bold;background:#94abf0;padding: 3px 1px;text-align:center;"><a href="http://se.goldgoldprice.com/" alt="英文字典中文字典" title="英文字典中文字典" id="word_name104_1" style="color:#000000;font-size:14px;text-decoration:none;line-height:16px;font-family: arial;" >英文字典中文字典</a></div><table width=100% style='align:center;text-align:left;font-size:12px;background-color:#ffffff;color:#333333;'>
<tr><td style="text-align:center;border:0"><input type=hidden name="word104_hi" value="1">输入中英文单字</td></tr><tr><td style="text-align:center;border:0"><input type="text" name="word104_input" value="" size=10 style="background-color:#ffffff;color:#000;text-decoration:none;font-family: arial;rial;border:1px solid #999;padding:1px!important;"></td></tr><tr style='line-height: 26px;'><td style="text-align:center;border:0"><input type=submit style="background-color:#ccc;color:#000;border:0 none;cursor:pointer;" value="查询字典"></td></tr></table></div>
</form>

英文字典中文字典相关资料:

Adstiladrin: Uses, Dosage, Side Effects Warnings - Drugs. com
Adstiladrin (nadofaragene firadenovec-vncg) is a gene therapy used to treat high-risk Bacillus CalmetteGuérin (BCG)-unresponsive non-muscle invasive bladder cancer Includes Adstiladrin side effects, interactions and indications
ADSTILADRIN® (nadofaragene firadenovec-vncg) | For HCP
Nadofaragene firadenovec- vncg (ADSTILADRIN) is A recommended treatment option: In the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)* and the AUA SUO Guidelines1 By the International Bladder Cancer Group (IBCG) for high-risk NMIBC after BCG failure for those seeking to avoid radical cystectomy 2
ADSTILADRIN | FDA
For the treatment of High-grade, Bacillus Calmette-Guerin (BCG) unresponsive non-muscle invasive bladder cancer
ADSTILADRIN® (nadofaragene firadenovec-vncg) | NMIBC Treatment
Adstiladrin is a prescription medicine for the treatment of adults with a type of cancer of the lining of the bladder called non-muscle invasive bladder cancer (NMIBC), that has not spread to other parts of the body, and that did not respond to treatment with Bacillus Calmette-Guérin (BCG)
Nadofaragene Firadenovec-vncg - NCI - National Cancer Institute
Nadofaragene firadenovec-vncg is approved to treat: Non-muscle–invasive bladder cancer with carcinoma in situ It is used in adults whose cancer does not respond to treatment with bacillus Calmette-Guérin (BCG) and has a high risk of coming back Nadofaragene firadenovec-vncg is also being studied in the treatment of other types of cancer
Ferring Announces Update to NCCN Guidelines Expanding . . .
ADSTILADRIN ® (nadofaragene firadenovec-vncg) is an FDA-approved intravesical non-replicating gene-therapy for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors (±Ta T1)
Adstiladrin | European Medicines Agency (EMA)
The full indication is: Adstiladrin is indicated as monotherapy for the treatment of adult patients with Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumours Adstiladrin will be available as a 3 x 10 11 viral particles ml intravesical suspension
Adstiladrin (Nadofaragene Firadenovec-vncg): Uses, Side . . .
Adstiladrin (Nadofaragene Firadenovec-vncg) represents a significant advancement in the treatment of certain types of bladder cancer This innovative gene therapy is designed to address high-risk, non-muscle invasive bladder cancer (NMIBC) that has not responded to standard Bacillus Calmette-Guérin (BCG) therapy Understanding its mechanism, proper administration, and potential side effects
Adstiladrin Bladder Cancer Treatment - The Urology Group Virginia
Adstiladrin (nadofaragene firadenovec-vncg) is a medicine used to treat adults with a type of bladder cancer called high-risk non-muscle invasive bladder cancer (NMIBC) that has not responded to a treatment called BCG It is for patients who have carcinoma in situ (CIS), with or without small growths called papillary tumors How does Adstiladrin work? Adstiladrin is a gene therapy It uses a
Nadofaragene firadenovec-vncg (urinary bladder route)
Description Nadofaragene Firadenovec-vncg is used to treat patients with high-risk Bacillus Calmette-Guerin (BCG)-unresponsive, non-muscle invasive bladder cancer (NMIBC) with a tumor type called carcinoma in situ (CIS) with or without papillary tumors This medicine is to be used only by or under the direct supervision of a doctor

中文字典-英文字典 2005-2009